The one-glance read on who they are and how they grow. Each point is verifiable from the receipts above.
An AI research assistant that automates literature reviews and evidence synthesis for scientists, spun out of nonprofit Ought and now pushing into pharma and life-sciences enterprise buyers, running on a $9M seed round raised from Fifty Years in 2023.
Organic-led, powered by founder technical content and global creator UGC, with a discrete enterprise-paid overlay for life sciences.
~1.73M monthly visits as of 2026-07-12; the founder's X account has 3,289 followers and 1,001 posts; LinkedIn's ad library shows 19 total ads with 4 active as of 2026-07-12.
As of 2026-07-12, the active LinkedIn ads center on conference and webinar moments (three are distinguishable in the library: a JPM26 networking mixer, a webinar recap, and a Bio-IT World causal-modeling talk) rather than evergreen product demand-gen creative.
Elicit runs two nearly disconnected motions on one product: unpaid, multilingual student-creator UGC feeds free-tier top-of-funnel volume, while a separate founder-and-cofounder-voiced paid/outbound track sells the same tool into pharma medical-affairs teams.
Live ad libraries: linkedin ad library · google ad library
Launch archives: Hacker News: Build a search engine, not a vector DB · Hacker News: SARS-CoV-2 infects human adipose tissue and elicits an infla · Hacker News: Unsupervised Elicitation of Language Models · Hacker News: Elicit – AI Research Assistant · Hacker News: Elicit · Hacker News: Scaling your impact: A polynomial model of career growth
Traffic, spend, and revenue figures are estimates as noted in the report; the links above are the primary public artifacts.
Today's teardown is free to read in full. Go Pro to unlock every past teardown: the launch, build-in-public, and content breakdowns, the channel scores, the full play list, and the creative library.
Go Pro to unlock →